Navigation Links
Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
Date:9/24/2007

18 have been diagnosed with asthma and the prevalence rates have more than doubled since 1980. For children under the age of 15, each year asthma accounts for 3.5 million doctor visits, 650,000 emergency room visits and 200,000 hospitalizations. The estimated annual cost of treating asthma in children under the age of 18 is $3.2 billion.

About Verus

Verus Pharmaceuticals is dedicated to improving the lives of children and those who care for them. Verus is building a portfolio of products for the unmet medical needs of children through acquisitions and alliances, with an initial focus on the treatment of asthma, allergies, and related diseases and conditions. Verus is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions. The company's rigorous, disciplined approach to strategic decision-making and core competencies in development and commercialization is expected to provide significant value to its partners. More information about Verus is available on the company's corporate website at http://www.veruspharm.com.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $26.47 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

Verus(R) is a registered trademark of Verus Pharmaceuticals, Inc. Captisol(R) is a registered trademark of CyDex, Inc. and eFlow(R) is a registered trademark of
'/>"/>

SOURCE Verus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Intestinal Disorders Caused By Overuse of antibiotics
2. Discontinuing Overused Pain Medications Helps Revert Migraines
3. Overuse Of Antibiotics-Creating Monsters Out Of Common Microbes
4. Epogen – Overuse Dangerou
5. Overuse of Popular Console can Cause Wiiitis in Gamers
6. Anemia Drug Overused and Could Hasten Death in Some, Say Experts
7. Supply of Radiopharmaceuticals Hampered by Attacks
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...10 don,t do enough to protect themselves from stro...HealthDay News) -- It,s one of medicine,s mantras:...lower it will have a dramatic impact on your risk ...cent of people with high blood pressure still aren...ng to a U.S. Centers for Disease Control and Preve...
(Date:11/21/2008)...UNTY, Calif., Nov. 21 Album Creati...irm, launches a new program offering big brand mar...aken the large, expensive ad agency process and se... a very hands-on approach," says Matt Parker, Crea... combines experience and proven brand-building tec...
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)...riz., Nov. 21 The Provid...announced that Craig A. Norris, the Company,s,Chi...mpany,s Board of,Directors. Mr. Norris, appointm...gnation of Steven I. Geringer and returns the boar...ny committee of the Board. , Mr. Norris, ag...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...nt positive side too, a study now reports. Bad gos...the study says that it may create or increase inti...in the June issue of the journal Personal Relation...egative attitudes that are frequently shared among...
...p of leading global health experts have come toget...ional donors// to negotiate affordable pricing of ...s of developing world countries and their partners...works and begin preparations for pneumococcal vacc...
...g of the American Society of Hypertension in New Y...e sexual dysfunction// (FSD) and high blood pressu...women with increased hypertension and increased ag...defined as persistent or recurring decrease in sex...
...brand new internet-based television show//: Pharma...PharmaVentures, says, ‘This show, the first in a m...eutical and biotechnology sectors with insightful ... transactions and industry trends. It gives exclus...
Other Medicine News:Health News:Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry 2Health News:Intro of Pneumococcal Vaccines: Experts Urge Commitment From Industry 3Health News:Link Established Between FSD and High Blood Pressure 2Health News:PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show 2
(Date:11/21/2008)...rstCall/ -- Amgen,(Nasdaq: AMGN ) today announc...ucts for Human Use (CHMP) has issued a positive op...late(TM) (romiplostim) in the European Union,(EU)...mune (idiopathic),thrombocytopenia purpura (ITP) ...er treatments (e.g. corticosteroids, immunoglobuli...
(Date:11/20/2008)...w Jersey American Water has lifted the precaution...following municipalities in Middlesex, Somerset an... , , Dunellen , Edison , ...nfield , , , , Somerset County , ..., Green Brook , Hillsborough , ...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...-- The Scandinavian-based drug,development compan... on its,lead antimicrobial candidate LTX-109. Pre...owed that the novel lytic peptidomimetic has an ul...ter towards killing Staphylococcus,aureus and Str...ugs. In,addition to this it has proven effective ...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 1NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 2NanoLogix Inc Presents at the National Hydrogen Association Conference 26 Provides Operations Management and Director Update 4275 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 1Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 2Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 4Study finds support for PCI in unprotected left main disease 15501 1Study finds support for PCI in unprotected left main disease 15501 2Study finds support for PCI in unprotected left main disease 15501 3Milestone Scientific Announces 2007 Year End Results 15497 1Milestone Scientific Announces 2007 Year End Results 15497 2Milestone Scientific Announces 2007 Year End Results 15497 3Milestone Scientific Announces 2007 Year End Results 15497 4Milestone Scientific Announces 2007 Year End Results 15497 5Milestone Scientific Announces 2007 Year End Results 15497 6Milestone Scientific Announces 2007 Year End Results 15497 7
Triad Plus Sterile Isopropyl Alcohol 70% USP Swabsticks are primarily used as a topical antiseptic prior to administering injections. They are gamma sterilized to meet AAMI/ANSI/ISO 11137 standar
...-I Prep Swabsticks are saturated with a 10% Po...vailable iodine. Povidone Iodine is virtually non-...is also non-staining to the skin or natural fabric...t; they are sturdy tools for removing small partic...
Aplicare's Saturated Swabsticks are packaged in easy open, single-use foil-laminated pouches. Each 4 inch Swabstick is saturated with precisely the correct amount of solution. Each package is termina
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
Medicine Products: